Q1 2025 · 13F-HR
TRV GP V, LLCholdings as filed
Filed 2025-05-09 · accession 0000950123-25-004485
$125.1M
Reported value
4
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 75383L102 | RAPP | RAPPORT THERAPEUTICS, INC. | $71.6M | 57.2% | 7,135,233 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA, INC. | $36.0M | 28.8% | 6,215,591 | Common | SOLE |
| 578784100 | MAZE | MAZE THERAPEUTICS, INC. | $10.5M | 8.37% | 950,800 | Common | SOLE |
| 14179K101 | CRGX | CARGO THERAPEUTICS, INC. | $7.1M | 5.65% | 1,737,216 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.